SJIA
PFE icon

St. James Investment Advisors’s Pfizer PFE Stock Holding History

St. James Investment Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.21M Buy
23,573
+1,033
+5% +$49.5K 2.21% 8
2022
Q3 		$986K Sell
22,540
-2,040
-8% -$99.1K 2.15% 12
2022
Q2 		$1.29M Sell
24,580
-59,498
-71% -$3.03M 2.61% 6
2022
Q1 		$4.35M Buy
84,078
+6,951
+9% +$361K 3.49% 6
2021
Q4 		$4.55M Buy
+77,127
New +$3.82M 3.36% 2

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

St. James Investment Advisors's PFE Position: Q4 2022 in Review

St. James Investment Advisors increased its Pfizer (PFE) stake by 4.6% in Q4 2022, buying an estimated $49.5K and bringing the position to 23,573 shares worth $1.21M. The position accounts for 2.21% of the portfolio, ranked #8.

St. James Investment Advisors first reported a position in PFE in Q4 2021 and has held it in 5 quarters since. The position peaked at $4.55M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • St. James Investment Advisors held 23,573 shares of Pfizer worth $1.21M as of Q4 2022.
  • St. James Investment Advisors bought 1,033 Pfizer shares in Q4 2022, an estimated $49.5K.
  • Pfizer made up 2.21% of St. James Investment Advisors's portfolio in Q4 2022, its #8 holding.
  • St. James Investment Advisors first reported a position in Pfizer in Q4 2021 and has held it in 5 quarters since.
  • St. James Investment Advisors's Pfizer position peaked at $4.55M in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on St. James Investment Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.